Search

As we reflect in this season of gratitude, MSK Kids, the pediatric cancer program at Memorial Sloan Kettering, is grateful for our pediatric patients and their families. Patients just like Rihanna.

… Tuesday, November 24, 2020 MSK Kid, Rihanna, and her family visit New York City to see her billboard. MSK Kid, Rihanna, and her family visit New York City to see her billboard. MSK Kid, Rihanna, and her family visit New York City to see her billboard. MSK Kid, Rihanna, and her family visit New York City

In a video interview and a panel discussion held at MSK last week, an eminent scientist, his family, and colleagues reflected on the experience of illness.

… Tuesday, November 22, 2016 Cancer immunologists Alan Houghton and Jedd Wolchok Alan Houghton (left) with colleague and former student Jedd Wolchok in 2004. Colin Houghton and Meryl Houghton Colin Houghton and Meryl Houghton From left to right: Colin, Meryl, and Sean Houghton; Jedd Wolchok; Paul Chapman

The drug targets a protein called HER2 found on some salivary gland tumors.

… Thursday, January 23, 2020 Albert Kuchler discussing his treatment results with MSK oncologist Bob Li at a recent clinic visit. Albert Kuchler discusses his excellent treatment results with MSK oncologist Bob Li at a recent clinic visit. MSK oncologist Bob Li Dr. Li is developing new clinical trials

Sergio Giralt, MD, has been appointed Chief of the Adult Bone Marrow Transplantation Service in the Division of Hematologic Oncology in the Department of Medicine at Memorial Sloan Kettering Cancer Center.

… Tuesday, June 1, 2010 Sergio Giralt, MD , has been appointed Chief of the Adult Bone Marrow Transplantation Service in the Division of Hematologic Oncology in the Department of Medicine at Memorial Sloan Kettering Cancer Center. “We’re very pleased to have Dr. Giralt, a recognized leader in the field

A prominent research grant will enable MSK doctors and scientists to advance the treatment of bladder cancer.

… Friday, May 31, 2019 Summary The National Cancer Institute recently awarded MSK a prestigious SPORE grant for bladder cancer research. Learn about how MSK researchers will use the $6.5 million award to gain insights into how the disease develops and responds to treatment. Bladder cancer is the fifth

Several types of cancer were once strongly linked to an AIDS diagnosis. Thanks to improved HIV medications, that's changing.

… Wednesday, April 3, 2019 Summary People with HIV are sometimes susceptible to getting specific types of cancer. This association has changed over the years, as drugs to control HIV infection have become available. When the AIDS epidemic began in 1981, many of the first reported cases were young gay men

A drug combination that halts tumor cell division can stir the immune system into taking action.

… Thursday, December 20, 2018 Summary According to scientists at the Sloan Kettering Institute, a two-drug combination that doesn’t directly kill tumor cells can still help as a cancer treatment. The key is activating the immune system. The goal of most cancer-fighting drugs is to kill tumor cells. But

In what is being hailed as a watershed moment for both cancer care and biotechnology, the US Food and Drug Administration has approved a personalized, cell-based immunotherapy for use in children and young adults with blood cancer. For more information or to arrange interviews, e-mail Caitlin Hool at [email protected].

… Tuesday, September 5, 2017 The FDA has approved a new type of immunotherapy called chimeric antigen receptor (CAR) T cell therapy . In this approach, scientists genetically engineer a patient’s own immune cells to make a new protein that can latch onto cancer. This turns them into supercharged cancer

A first-in-class allogeneic CAR T cell therapy regimen demonstrated feasibility and acceptable safety with preliminary evidence of efficacy in patients with heavily pretreated multiple myeloma, according to interim results from the phase 1 UNIVERSAL trial (NCT04093596) published recently in Nature Medicine.

… Wednesday, February 15, 2023 A first-in-class allogeneic CAR T cell therapy regimen demonstrated feasibility and acceptable safety with preliminary evidence of efficacy in patients with heavily pretreated multiple myeloma, according to interim results from the phase 1 UNIVERSAL trial ( NCT04093596 )

NBC News anchor Craig Melvin led MSK experts in a discussion about racial and age trends in colorectal cancer and when people should start screening for the disease.

… Monday, September 19, 2022 NBC News’ Today Show anchor and co-host Craig Melvin led a discussion at Memorial Sloan Kettering Cancer Center (MSK) in March 2022 with colorectal oncologists  Fiyinfolu Balogun  and  Andrea Cercek and gastroenterologist  Robin Mendelsohn . Drs. Cercek and Mendelsohn are Co-Directors